Literature DB >> 20837968

Sensory ganglionopathy due to gluten sensitivity.

M Hadjivassiliou1, D G Rao, S B Wharton, D S Sanders, R A Grünewald, A G B Davies-Jones.   

Abstract

OBJECTIVES: Gluten sensitivity can engender neurologic dysfunction, one of the two commonest presentations being peripheral neuropathy. The commonest type of neuropathy seen in the context of gluten sensitivity is sensorimotor axonal. We report 17 patients with sensory ganglionopathy associated with gluten sensitivity.
METHODS: This is a retrospective observational case series of 17 patients with sensory ganglionopathy and gluten sensitivity. All patients had been followed up for a number of years in dedicated gluten sensitivity/neurology and neuropathy clinics.
RESULTS: Out of a total of 409 patients with different types of peripheral neuropathies, 53 (13%) had clinical and neurophysiologic evidence of sensory ganglionopathy. Out of these 53 patients, 17 (32%) had serologic evidence of gluten sensitivity. The mean age of those with gluten sensitivity was 67 years and the mean age at onset was 58 years. Seven of those with serologic evidence of gluten sensitivity had enteropathy on biopsy. Fifteen patients went on a gluten-free diet, resulting in stabilization of the neuropathy in 11. The remaining 4 had poor adherence to the diet and progressed, as did the 2 patients who did not opt for dietary treatment. Autopsy tissue from 3 patients demonstrated inflammation in the dorsal root ganglia with degeneration of the posterior columns of the spinal cord.
CONCLUSIONS: Sensory ganglionopathy can be a manifestation of gluten sensitivity and may respond to a strict gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837968     DOI: 10.1212/WNL.0b013e3181f25ee0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Gliadin allergy manifested with chronic urticaria, headache and amenorrhea.

Authors:  Ervin Ç Mingomataj; Enkelejda Gjata; Alketa Bakiri; Fatmira Xhixha; Entela Hyso; Alkerta Ibranji
Journal:  BMJ Case Rep       Date:  2011-12-02

2.  The neurologic significance of celiac disease biomarkers.

Authors:  Andrew McKeon; Vanda A Lennon; Sean J Pittock; Thomas J Kryzer; Joseph Murray
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

Review 3.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 4.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

Review 5.  Immune-Mediated Neurological Disorders.

Authors:  Teerin Liewluck; Augusto Miravalle
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

6.  Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2018-07-21       Impact factor: 4.849

Review 7.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 8.  Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.

Authors:  Anne Louise Oaklander
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 9.  The ataxic neuropathies.

Authors:  Stéphane Mathis; Fanny Duval; Antoine Soulages; Guilhem Solé; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849

Review 10.  The Intersection Between Cerebellar Ataxia and Neuropathy: a Proposed Classification and a Diagnostic Approach.

Authors:  Cristina Saade Jaques; Marcio Luiz Escorcio-Bezerra; José Luiz Pedroso; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2021-08-09       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.